Department of Neurology, Beijing Jishuitan Hospital, Beijing, China.
Eur Rev Med Pharmacol Sci. 2019 Jul;23(14):6264-6271. doi: 10.26355/eurrev_201907_18447.
To explore the influences of toll-like receptor 4/nuclear factor-κB (TLR4/NF-κB) pathway on the memory function and inflammatory factors in rats with cerebral small vessel disease (CSVD).
CSVD model in rats was established. Expressions of TLR4/NF-κB-related proteins and inflammatory factors were detected. CSVD rats were treated with the TLR4/NF-κB pathway agonist and inhibitor to evaluate the regulatory effect of TLR4/NF-κB pathway on the expressions of TLR4, NF-κB p50 and NF-κB p65. Moreover, their influences on the cerebral edema, memory function and expressions of inflammatory factors [interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α)] in CSVD rats were also analyzed.
In model group, the mRNA and protein expressions of TLR4 and NF-κB-related proteins in rat hippocampus were significantly higher than those in sham group (p<0.01), and the expressions of IL-1β and TNF-αsignificantly increased (p<0.05). The agonist lipopolysaccharide (LPS) significantly increased the proportion of TLR4-positive cells (p<0.01) and protein expression of TLR4 (p<0.01). The inhibitor CLI-095 obviously reduced the proportion of TLR4-positive cells and TLR4 expression (p<0.05). Pyrrolidine dithiocarbamate (PDTC) remarkably reduced the expressions of NF-κB p50 and NF-κB p65 in model group (p<0.05). LPS promoted cerebral edema, leading to memory dysfunction and enhanced inflammatory response in rats of model group. The inhibitor CLI-095+PDTC significantly reduced cerebral edema, lowered memory impairment and relieved inflammatory response in CSVD rats (p<0.05).
The inhibitor of the TLR4/NF-κB signaling pathway can restore memory function and reduce inflammatory response in CSVD rats.
探讨 Toll 样受体 4/核因子-κB(TLR4/NF-κB)通路对脑小血管病(CSVD)大鼠记忆功能和炎症因子的影响。
建立 CSVD 大鼠模型。检测 TLR4/NF-κB 相关蛋白和炎症因子的表达。用 TLR4/NF-κB 通路激动剂和抑制剂处理 CSVD 大鼠,评估 TLR4/NF-κB 通路对 TLR4、NF-κB p50 和 NF-κB p65 表达的调节作用。此外,还分析了它们对 CSVD 大鼠脑水肿、记忆功能和炎症因子[白细胞介素-1β(IL-1β)和肿瘤坏死因子-α(TNF-α)]表达的影响。
在模型组,大鼠海马 TLR4 和 NF-κB 相关蛋白的 mRNA 和蛋白表达均明显高于假手术组(p<0.01),IL-1β 和 TNF-α 的表达明显增加(p<0.05)。TLR4 激动剂脂多糖(LPS)显著增加 TLR4 阳性细胞的比例(p<0.01)和 TLR4 蛋白的表达(p<0.01)。抑制剂 CLI-095 明显降低 TLR4 阳性细胞和 TLR4 表达的比例(p<0.05)。吡咯烷二硫代氨基甲酸盐(PDTC)显著降低模型组 NF-κB p50 和 NF-κB p65 的表达(p<0.05)。LPS 促进脑水肿,导致模型组大鼠记忆功能障碍和炎症反应增强。抑制剂 CLI-095+PDTC 可显著减轻 CSVD 大鼠脑水肿,降低记忆障碍,减轻炎症反应(p<0.05)。
TLR4/NF-κB 信号通路抑制剂可恢复 CSVD 大鼠的记忆功能,减轻炎症反应。